Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 11 | $4,727,157 |
| Sells | 30 | $3,873,998 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 15 Nov 2024 17:34 | MIRM | Mirum Pharmaceuticals Inc | HOWE JOLANDA | SVP, GLOBAL CONTROLLER | 14 Nov 2024 | Sale | 2,500 | 47.1008 | 117,752 | D |
| 20 Sep 2024 16:39 | MIRM | Mirum Pharmaceuticals Inc | HERON PATRICK J | Director | 18 Sep 2024 | Purchase | 115 | 37.4 | 4,301 | I |
| 10 Sep 2024 17:04 | MIRM | Mirum Pharmaceuticals Inc | HERON PATRICK J | Director | 06 Sep 2024 | Purchase | 230 | 41.5783 | 9,563 | I |
| 03 Jul 2024 18:19 | MIRM | Mirum Pharmaceuticals Inc | HOWE JOLANDA | SVP, GLOBAL CONTROLLER | 02 Jul 2024 | Sale | 375 | 34 | 12,750 | D |
| 25 Jun 2024 17:15 | MIRM | Mirum Pharmaceuticals Inc | VIG PAMELA | CHIEF SCIENTIFIC OFFICER | 24 Jun 2024 | Sale | 30,559 | 34 | 1,039,006 | D |
| 07 Jun 2024 18:20 | MIRM | Mirum Pharmaceuticals Inc | RAMASASTRY SAIRA | Director | 05 Jun 2024 | Sale | 5,000 | 25.68 | 128,400 | D |
| 27 Mar 2024 20:47 | MIRM | Mirum Pharmaceuticals Inc | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Purchase | 2,000 | 24.8 | 49,600 | D |
| 25 Mar 2024 17:41 | MIRM | Mirum Pharmaceuticals Inc | RADOVICH PETER | PRESIDENT AND COO | 25 Mar 2024 | Sale | 4,303 | 25.8 | 111,017 | D |
| 18 Mar 2024 17:46 | MIRM | Mirum Pharmaceuticals Inc | RADOVICH PETER | PRESIDENT AND COO | 09 Jan 2023 | Sale | 1,379 | 20.6223 | 28,438 | D |
| 18 Mar 2024 17:44 | MIRM | Mirum Pharmaceuticals Inc | VIG PAMELA | CHIEF SCIENTIFIC OFFICER | 09 Jan 2023 | Sale | 1,379 | 20.6223 | 28,438 | D |
| 18 Mar 2024 17:40 | MIRM | Mirum Pharmaceuticals Inc | LONGPRE LARA | CHIEF DEVELOPMENT OFFICER | 09 Jan 2023 | Sale | 1,003 | 20.6223 | 20,684 | D |
| 18 Mar 2024 17:40 | MIRM | Mirum Pharmaceuticals Inc | LONGPRE LARA | CHIEF DEVELOPMENT OFFICER | 10 Sep 2019 | Purchase | 965 | 10.64 | 10,268 | D |
| 18 Mar 2024 17:37 | MIRM | Mirum Pharmaceuticals Inc | PEETZ CHRISTOPHER | CHIEF EXECUTIVE OFFICER | 09 Jan 2023 | Sale | 5,159 | 20.6223 | 106,390 | D |
| 18 Mar 2024 17:34 | MIRM | Mirum Pharmaceuticals Inc | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | 18 Mar 2024 | Purchase | 2,000 | 25.8 | 51,600 | D |
| 05 Feb 2024 21:12 | MIRM | Mirum Pharmaceuticals Inc | VIG PAMELA | CHIEF SCIENTIFIC OFFICER | 02 Feb 2024 | Sale | 1,214 | 26.1918 | 31,797 | D |
| 05 Feb 2024 21:10 | MIRM | Mirum Pharmaceuticals Inc | LONGPRE LARA | CHIEF DEVELOPMENT OFFICER | 02 Feb 2024 | Sale | 847 | 26.1918 | 22,184 | D |
| 05 Feb 2024 21:05 | MIRM | Mirum Pharmaceuticals Inc | RADOVICH PETER | PRESIDENT AND COO | 02 Feb 2024 | Sale | 1,790 | 26.1917 | 46,883 | D |
| 05 Feb 2024 21:04 | MIRM | Mirum Pharmaceuticals Inc | PEETZ CHRISTOPHER | CHIEF EXECUTIVE OFFICER | 02 Feb 2024 | Sale | 6,013 | 26.1918 | 157,491 | D |
| 02 Feb 2024 21:28 | MIRM | Mirum Pharmaceuticals Inc | HOWE JOLANDA | SVP, GLOBAL CONTROLLER | 02 Feb 2024 | Sale | 735 | 26.1918 | 19,251 | D |
| 09 Jan 2024 20:28 | MIRM | Mirum Pharmaceuticals Inc | RADOVICH PETER | CHIEF OPERATING OFFICER | 08 Jan 2024 | Sale | 1,408 | 28.0345 | 39,473 | D |
| 09 Jan 2024 20:25 | MIRM | Mirum Pharmaceuticals Inc | LONGPRE LARA | CHIEF DEVELOPMENT OFFICER | 08 Jan 2024 | Sale | 1,019 | 28.035 | 28,568 | D |
| 09 Jan 2024 20:21 | MIRM | Mirum Pharmaceuticals Inc | VIG PAMELA | HEAD OF RESEARCH & DEVELOPMENT | 08 Jan 2024 | Sale | 1,408 | 28.0343 | 39,472 | D |
| 09 Jan 2024 20:12 | MIRM | Mirum Pharmaceuticals Inc | PEETZ CHRISTOPHER | PRESIDENT AND CEO | 08 Jan 2024 | Sale | 5,209 | 28.0348 | 146,033 | D |
| 09 Jan 2024 20:09 | MIRM | Mirum Pharmaceuticals Inc | HOWE JOLANDA | SVP, GLOBAL CONTROLLER | 08 Jan 2024 | Sale | 528 | 28.0351 | 14,803 | D |
| 06 Dec 2023 17:16 | MIRM | Mirum Pharmaceuticals Inc | HOWE JOLANDA | SVP, Global Controller | 05 Dec 2023 | Sale | 2,500 | 32.4 | 81,000 | D |
| 14 Nov 2023 16:35 | MIRM | Mirum Pharmaceuticals Inc | HERON PATRICK J | Director | 09 Nov 2023 | Purchase | 2,910 | 28.3 | 82,353 | I |
| 15 Sep 2023 16:56 | MIRM | Mirum Pharmaceuticals Inc | HERON PATRICK J | Director | 13 Sep 2023 | Purchase | 2,625 | 31.019 | 81,425 | I |
| 14 Sep 2023 19:33 | MIRM | Mirum Pharmaceuticals Inc | GREY MICHAEL G | Director | 13 Sep 2023 | Sale | 392 | 32 | 12,544 | D |
| 14 Sep 2023 19:33 | MIRM | Mirum Pharmaceuticals Inc | GREY MICHAEL G | Director | 14 Sep 2023 | Sale | 14,216 | 32 | 454,912 | D |
| 13 Sep 2023 16:39 | MIRM | Mirum Pharmaceuticals Inc | HERON PATRICK J | Director | 12 Sep 2023 | Purchase | 3,750 | 30.6037 | 114,764 | I |
| 13 Sep 2023 16:39 | MIRM | Mirum Pharmaceuticals Inc | HERON PATRICK J | Director | 11 Sep 2023 | Purchase | 4,687 | 30.3024 | 142,027 | I |
| 12 Sep 2023 18:23 | MIRM | Mirum Pharmaceuticals Inc | BJERKHOLT ERIC | Chief Financial Officer | 11 Sep 2023 | Purchase | 10,000 | 29.6492 | 296,492 | D |
| 05 Sep 2023 12:51 | MIRM | Mirum Pharmaceuticals Inc | HERON PATRICK J | Director , 10% | 31 Aug 2023 | Purchase | 147,991 | 26.25 | 3,884,764 | I |
| 28 Aug 2023 16:30 | MIRM | Mirum Pharmaceuticals Inc | HOWE JOLANDA | SVP, Global Controller | 25 Aug 2023 | Sale | 3,459 | 26.2339 | 90,743 | D |
| 05 Jul 2023 19:47 | MIRM | Mirum Pharmaceuticals Inc | RADOVICH PETER | Chief Operating Officer | 03 Jul 2023 | Sale | 1,425 | 25.6466 | 36,546 | D |
| 05 Jul 2023 19:37 | MIRM | Mirum Pharmaceuticals Inc | LONGPRE LARA | Chief Development Officer | 03 Jul 2023 | Sale | 1,004 | 25.6466 | 25,749 | D |
| 05 Jul 2023 19:35 | MIRM | Mirum Pharmaceuticals Inc | VIG PAMELA | Head of Research & Development | 03 Jul 2023 | Sale | 1,425 | 25.6466 | 36,546 | D |
| 05 Jul 2023 19:33 | MIRM | Mirum Pharmaceuticals Inc | HOWE JOLANDA | SVP, Global Controller | 03 Jul 2023 | Sale | 915 | 25.6466 | 23,467 | D |
| 05 Jul 2023 19:30 | MIRM | Mirum Pharmaceuticals Inc | PEETZ CHRISTOPHER | President and CEO | 03 Jul 2023 | Sale | 5,498 | 25.6466 | 141,005 | D |
| 09 Jun 2023 16:20 | MIRM | Mirum Pharmaceuticals Inc | GREY MICHAEL G | Director | 08 Jun 2023 | Sale | 14,608 | 29 | 423,632 | D |
| 04 May 2023 21:58 | MIRM | Mirum Pharmaceuticals Inc | GREY MICHAEL G | Director | 03 May 2023 | Sale | 14,608 | 28 | 409,024 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)